JP2006527751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006527751A5 JP2006527751A5 JP2006516435A JP2006516435A JP2006527751A5 JP 2006527751 A5 JP2006527751 A5 JP 2006527751A5 JP 2006516435 A JP2006516435 A JP 2006516435A JP 2006516435 A JP2006516435 A JP 2006516435A JP 2006527751 A5 JP2006527751 A5 JP 2006527751A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- formula
- thio
- hydroxyphenyl
- phenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000012442 inert solvent Substances 0.000 claims 4
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 3
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 235000019260 propionic acid Nutrition 0.000 claims 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- -1 2- {4-[(methylsulfonyl) oxy] phenoxy} ethyl Chemical group 0.000 claims 1
- PGZGQQFVPOZCAQ-UHFFFAOYSA-N 2-[2-(4-hydroxyphenyl)ethylsulfanyl]-3-[4-[2-(4-methylsulfonyloxyphenoxy)ethyl]phenyl]propanoic acid Chemical compound C1=CC(OS(=O)(=O)C)=CC=C1OCCC(C=C1)=CC=C1CC(C(O)=O)SCCC1=CC=C(O)C=C1 PGZGQQFVPOZCAQ-UHFFFAOYSA-N 0.000 claims 1
- 239000005046 Chlorosilane Substances 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 230000006340 racemization Effects 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
Claims (9)
- 不活性溶媒中、塩基と1種のエナンチオマーに富む2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を反応させることを含む、実質的にラセミ体の2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を製造するための方法。
- ラセミ化前、またはラセミ化中に酸がエステルに変換される、請求項1に記載の方法。
- ラセミ化されたエステルが次に加水分解されてラセミ体の酸を生じる、請求項2に記載の方法。
- 温度0〜150℃の範囲で、不活性溶媒存在中、含窒素塩基の存在下でハロシランと1種のエナンチオマーに富む2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を反応させることを含む、請求項1に記載の方法。
- 温度0〜150℃の範囲で、不活性溶媒存在中、1,8ジアザビシクロ[5.4.0]ウンデク−7−エンの存在下で、クロロトリメチルシランと1種のエナンチオマーに富む2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を反応させることを含む、実質的にラセミ体の2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を製造するための方法。
- 式Iの化合物による脂質疾患の処置方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0314260.1A GB0314260D0 (en) | 2003-06-19 | 2003-06-19 | Therapeutic agents |
PCT/GB2004/002599 WO2004113285A1 (en) | 2003-06-19 | 2004-06-16 | Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006527751A JP2006527751A (ja) | 2006-12-07 |
JP2006527751A5 true JP2006527751A5 (ja) | 2007-07-05 |
Family
ID=27636892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006516435A Withdrawn JP2006527751A (ja) | 2003-06-19 | 2004-06-16 | ラセミ体の2−{[2−(4−ヒドロキシフェニル)エチル]チオ}−3−[4−(2−{4−[(メチルスルホニル)オキシ]フェノキシ}エチル)フェニル]プロパン酸を製造するための方法 |
Country Status (14)
Country | Link |
---|---|
US (1) | US7429675B2 (ja) |
EP (1) | EP1638929A1 (ja) |
JP (1) | JP2006527751A (ja) |
KR (1) | KR20060010840A (ja) |
CN (1) | CN1835918A (ja) |
AU (1) | AU2004249487A1 (ja) |
BR (1) | BRPI0411450A (ja) |
CA (1) | CA2529252A1 (ja) |
GB (1) | GB0314260D0 (ja) |
IL (1) | IL172376A0 (ja) |
MX (1) | MXPA05013716A (ja) |
NO (1) | NO20055883L (ja) |
WO (1) | WO2004113285A1 (ja) |
ZA (1) | ZA200509944B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
DE60319084T2 (de) | 2002-06-20 | 2009-01-29 | Astrazeneca Ab | Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz |
GB0314075D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0427524D0 (en) | 2004-12-16 | 2005-01-19 | Astrazeneca Ab | Chemical process |
RU2480453C2 (ru) * | 2007-03-08 | 2013-04-27 | Альбирео Аб | Новые соединения |
FR2986804A1 (fr) * | 2012-02-09 | 2013-08-16 | Servier Lab | Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0193113B1 (en) * | 1985-02-25 | 1992-01-22 | Mitsubishi Gas Chemical Company, Inc. | Process for optically isomerizing optically active alpha-amino acid amides and process for producing optically active alpha-amino acids |
JPS61197530A (ja) | 1985-02-25 | 1986-09-01 | Mitsubishi Gas Chem Co Inc | ラセミ化法 |
TW472047B (en) * | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-19 GB GBGB0314260.1A patent/GB0314260D0/en not_active Ceased
-
2004
- 2004-06-16 CN CNA2004800231458A patent/CN1835918A/zh active Pending
- 2004-06-16 JP JP2006516435A patent/JP2006527751A/ja not_active Withdrawn
- 2004-06-16 MX MXPA05013716A patent/MXPA05013716A/es unknown
- 2004-06-16 US US10/561,161 patent/US7429675B2/en not_active Expired - Fee Related
- 2004-06-16 AU AU2004249487A patent/AU2004249487A1/en not_active Abandoned
- 2004-06-16 BR BRPI0411450-7A patent/BRPI0411450A/pt not_active IP Right Cessation
- 2004-06-16 KR KR1020057024130A patent/KR20060010840A/ko not_active Application Discontinuation
- 2004-06-16 WO PCT/GB2004/002599 patent/WO2004113285A1/en active Application Filing
- 2004-06-16 CA CA002529252A patent/CA2529252A1/en not_active Abandoned
- 2004-06-16 EP EP04736920A patent/EP1638929A1/en not_active Withdrawn
-
2005
- 2005-12-05 IL IL172376A patent/IL172376A0/en unknown
- 2005-12-07 ZA ZA200509944A patent/ZA200509944B/en unknown
- 2005-12-12 NO NO20055883A patent/NO20055883L/no not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101699095B1 (ko) | 2-아실아미노-3-디페닐프로판산의 제조 및 분할 방법 | |
JP2010539076A5 (ja) | ||
JP2007505891A5 (ja) | ||
JP2005539045A5 (ja) | ||
JP2012515142A5 (ja) | ||
US20070287839A1 (en) | Novel process for the preparation of esomeprazole and salts thereof | |
JP2006527751A5 (ja) | ||
JP2005500322A (ja) | 3−フェニルイソセリンの製法 | |
WO2008106900A1 (en) | Method of manufacturing (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4 -fluorophenyl) -3-hydroxypropyl) ] -4- (4-hyd roxyphenyl) -2-azetidinone | |
JP2005536484A (ja) | 光学活性(r)−アリールオキシプロピオン酸エステル誘導体の製造方法 | |
JP2020073474A5 (ja) | ||
ZA200509944B (en) | Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid | |
KR101073742B1 (ko) | α-(페녹시)페닐아세트산 유도체의 분리 | |
JP2007524614A (ja) | α−(フェノキシ)フェニル酢酸誘導体の分割 | |
KR20100035597A (ko) | 몬테루카스트 나트륨염의 제조방법 | |
JP2008546767A5 (ja) | ||
JP7109056B2 (ja) | S-icaリボシルホモシステインの製造方法 | |
EP2172464B1 (en) | A method for the preparation of the hydrochloride salt from the duloxetine base | |
JP2003522122A (ja) | 置換ピペリジン−4−オンの製造 | |
JP2013173677A (ja) | (1r,2s)−1−アミノ−2−ビニルシクロプロパンカルボン酸エステルの製造法 | |
JP2008105970A (ja) | ジヒドロキノリン誘導体の製造方法及びその中間体 | |
JP2005538126A5 (ja) | ||
JP2014520796A5 (ja) | ||
JP2007506794A5 (ja) | ||
CN1257166C (zh) | 制备具有抗组胺活性的三环化合物的方法 |